Pharmalyte Solutions LLC Report issue

For profit Phase 3
Founded: Dallas TX United States (2012)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2015
NCT02322333
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Pharmalyte Solutions LLC

Active Ingredients

Drugs in Phase 3 Trials (1)

magnesium lactate (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Migraine Disorders (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1